Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ani Pharmaceuticals (ANIP) Other Non-Current Liabilities (2016 - 2025)

Ani Pharmaceuticals (ANIP) has disclosed Other Non-Current Liabilities for 12 consecutive years, with $9.6 million as the latest value for Q4 2025.

  • Quarterly Other Non-Current Liabilities fell 11.83% to $9.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $9.6 million through Dec 2025, down 11.83% year-over-year, with the annual reading at $9.6 million for FY2025, 11.83% down from the prior year.
  • Other Non-Current Liabilities hit $9.6 million in Q4 2025 for Ani Pharmaceuticals, down from $11.3 million in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $32.1 million in Q1 2022 to a low of $1.0 million in Q2 2022.
  • Historically, Other Non-Current Liabilities has averaged $8.9 million across 5 years, with a median of $8.8 million in 2021.
  • Biggest YoY gain for Other Non-Current Liabilities was 1089.81% in 2023; the steepest drop was 96.25% in 2023.
  • Year by year, Other Non-Current Liabilities stood at $7.8 million in 2021, then crashed by 82.3% to $1.4 million in 2022, then surged by 248.23% to $4.8 million in 2023, then soared by 126.66% to $10.9 million in 2024, then decreased by 11.83% to $9.6 million in 2025.
  • Business Quant data shows Other Non-Current Liabilities for ANIP at $9.6 million in Q4 2025, $11.3 million in Q3 2025, and $6.7 million in Q2 2025.